Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism.
about
Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction.Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model.Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunctionNew achievements and pharmacotherapeutic approaches to impotence in the elderly.Erectile dysfunction and hypertension: impact on cardiovascular risk and treatmentAndrogen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1-eNOS axisBasic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review.Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.Testosterone, endothelial health, and erectile function.Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway.Sildenafil citrate vs intracavernous alprostadil for patients with arteriogenic erectile dysfunction: a randomised placebo controlled study.Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase.Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat.The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil.Comparative analysis of the penis corpora cavernosa in controls and patients with erectile dysfunction.The effect of electrocoagulation on the sinusoids in the human penis.Relationship between Response to PDE5 Inhibitors and Penile Duplex Doppler Ultrasound in Erectile Dysfunction.
P2860
Q34564998-9FDDF13F-8BB9-4D24-82E7-7B5766000B69Q35129129-15EA515E-4A01-4155-9D75-3953F89D6B93Q35154128-3C7D1AB0-5E40-4C59-91EC-CC54D1F8ADB1Q35569842-032664DE-85DB-43F0-85CD-F972A18F2CC1Q35977540-C8E8C1D8-D524-4BF2-AA2C-3F7D1CC224D9Q36528250-3DED6CFA-CC32-4066-8E0A-8C653E940BD5Q36861695-7DB48B13-A76F-447E-97A2-3CE572D4EA7FQ36900830-1589152D-4DA3-4172-A925-FD785E6E97D1Q37733556-8E638F3A-F6ED-4E0C-AB87-4C5EE9D295EDQ40549792-A044A960-7DFA-4B6C-82E4-71B5F3F8DBC8Q42781883-9DE036D1-8398-450F-BDF5-50A1695CA339Q44764451-9A45FCE8-9275-41E5-B796-82358ADE4F32Q45887184-0D78003B-B34E-412D-B71E-694A65848553Q48459547-6A075C90-F6DC-410A-9F12-FFCF6ED00369Q48731350-517E573A-261E-4B5D-B1B5-BE1D97EF3203Q51274086-6412BE8E-4EB8-4AD2-BFF4-ADB70130BB1BQ53283785-5AF91E43-AA51-4F95-A84B-B1E8F3809E0EQ55413053-BEFEC060-D8CE-4166-A974-7BA13A1AB4E0
P2860
Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pathophysiology of erectile dy ...... role of functional antagonism.
@ast
Pathophysiology of erectile dy ...... role of functional antagonism.
@en
Pathophysiology of erectile dy ...... role of functional antagonism.
@nl
type
label
Pathophysiology of erectile dy ...... role of functional antagonism.
@ast
Pathophysiology of erectile dy ...... role of functional antagonism.
@en
Pathophysiology of erectile dy ...... role of functional antagonism.
@nl
prefLabel
Pathophysiology of erectile dy ...... role of functional antagonism.
@ast
Pathophysiology of erectile dy ...... role of functional antagonism.
@en
Pathophysiology of erectile dy ...... role of functional antagonism.
@nl
P356
P1476
Pathophysiology of erectile dy ...... role of functional antagonism.
@en
P2093
Moreland RB
P2888
P304
P356
10.1038/SJ.IJIR.3900576
P478
12 Suppl 4
P577
2000-10-01T00:00:00Z
P5875
P6179
1041259374